Nettis, E., Masciopinto, L., Di Leo, E., De Candia, N., Albanesi, M., Di Bona, D., . . . Macchia, L. (2021). Dupilumab elicits a favorable response in type-2 inflammatory comorbidities of severe atopic dermatitis. Clin Mol Allergy.

Nettis, Eustachio, Lucia Masciopinto, Elisabetta Di Leo, Nicola De Candia, Marcello Albanesi, Danilo Di Bona, Nicola Quaranta, och Luigi Macchia. "Dupilumab Elicits a Favorable Response in Type-2 Inflammatory Comorbidities of Severe Atopic Dermatitis." Clin Mol Allergy 2021.

Nettis, Eustachio, et al. "Dupilumab Elicits a Favorable Response in Type-2 Inflammatory Comorbidities of Severe Atopic Dermatitis." Clin Mol Allergy 2021.